首页> 外文OA文献 >Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

【2h】

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

机译：黄体激素释放激素长期治疗前列腺癌未能抑制血清黄体激素和睾丸激素水平。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ahmed, S R; Shalet, S M; Grant, J; Howell, A; Blacklock, N J;
展开▼
作者单位

展开▼
年度 1984
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer [J] . P. Mongiat-Artus, P. Teillac~R European urology supplements: official journal of the European Association of Urology . 2005,第5期

机译：黄体激素释放激素（LHRH）激动剂和激素治疗在前列腺癌管理中的作用
2. 385 A phase II trial to assess the efficacy and safety of gefitinib (Iressa?) in patients with metastatic hormone refractory prostate cancer (HRPC) who progressed on treatment with a luteinising hormone releasing hormone analogue (or post orchiectomy) plus an antiandrogen [J] . G.Curigliano, O.De Cobelli, M.T.Sandri, European Journal of Cancer Supplements . 2004,第8期

机译：385一项II期临床试验，评估吉非替尼（Iressa？）在使用黄体激素释放激素类似物（或睾丸切除术后）加抗雄激素治疗的转移性激素难治性前列腺癌（HRPC）患者中的疗效和安全性
3. Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer [J] . Gilbert Duncan C., Trinh Duong, Kynaston Howard G., BJU international . 2017,第5期

机译：前列腺腺癌的生活质量结果：经皮荷尔蒙（补丁）试验评估旋光激素释放激素激动剂与透皮癌症在晚期前列腺癌中的疾病抑制作用
4. Relationships among metabolic hormones, luteinising hormone and anoestrus in periparturient dairy heifers fed two nutritional levels prepartum [C] . A.B. PLEASANTS, L.M. CHAGAS, C.R. BURKE, Conference of the New Zealand Society of Animal Production . 2005

机译：代谢激素的关系，围网乳房小母牛中的旋曲激素和Anoestrus喂养了两种营养水平预备
5. Changes in bone mineral density in men with prostate cancer during treatment with luteinizing hormone-releasing hormone (LHRH) agonist monotherapy. [D] . Conde, Francisco Alcasid, II. 2003

机译：黄体激素释放激素（LHRH）激动剂单药治疗期间前列腺癌男性的骨矿物质密度变化。
6. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. [O] . D Kerle, G Williams, H Ware, 1984

机译：黄体激素释放激素长期治疗前列腺癌未能抑制血清黄体激素和睾丸激素水平。
7. Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. [O] . Kerle, D, Williams, G, Ware, H, 1984

机译：黄体激素释放激素长期治疗前列腺癌未能抑制血清黄体激素和睾丸激素水平。

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.

著录项

引文网络

相似文献

相关主题

期刊订阅